- Home
- ALZN vs FEBO Comparison
ALZN vs FEBO Comparison
Compare ALZN & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- FEBO
- Stock Information
- Founded
- ALZN 2016
- FEBO 1993
- Country
- ALZN United States
- FEBO Hong Kong
- Employees
- ALZN N/A
- FEBO N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- FEBO
- Sector
- ALZN Health Care
- FEBO
- Exchange
- ALZN Nasdaq
- FEBO Nasdaq
- Market Cap
- ALZN 7.5M
- FEBO 8.3M
- IPO Year
- ALZN 2021
- FEBO 2023
- Fundamental
- Price
- ALZN $2.35
- FEBO $0.78
- Analyst Decision
- ALZN Strong Buy
- FEBO
- Analyst Count
- ALZN 1
- FEBO 0
- Target Price
- ALZN $42.00
- FEBO N/A
- AVG Volume (30 Days)
- ALZN 132.3K
- FEBO 29.6K
- Earning Date
- ALZN 12-11-2025
- FEBO 11-11-2025
- Dividend Yield
- ALZN N/A
- FEBO N/A
- EPS Growth
- ALZN N/A
- FEBO N/A
- EPS
- ALZN N/A
- FEBO N/A
- Revenue
- ALZN N/A
- FEBO $17,110,653.00
- Revenue This Year
- ALZN N/A
- FEBO N/A
- Revenue Next Year
- ALZN N/A
- FEBO N/A
- P/E Ratio
- ALZN N/A
- FEBO N/A
- Revenue Growth
- ALZN N/A
- FEBO 11.58
- 52 Week Low
- ALZN $2.06
- FEBO $0.61
- 52 Week High
- ALZN $15.21
- FEBO $4.47
- Technical
- Relative Strength Index (RSI)
- ALZN 48.08
- FEBO 54.79
- Support Level
- ALZN $2.27
- FEBO $0.77
- Resistance Level
- ALZN $2.56
- FEBO $0.82
- Average True Range (ATR)
- ALZN 0.16
- FEBO 0.05
- MACD
- ALZN 0.01
- FEBO 0.01
- Stochastic Oscillator
- ALZN 50.71
- FEBO 77.69
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.